「余量」这个新终点自己够不够格:MDC95 的层级混用,和年龄这个跑不掉的混杂

Written by

in

Language

Evidence level: C

在问「修炼者的余量是不是更大」之前,得先问「这个余量在本设计里量得准不准」——而常见的写法恰好答错了这道题:它拿个体层面的门槛去卡组层面的差异。

正文

上一篇把「沉而不塌」从 X5 电平改判成「呼气末到 DR2 的距离」,并给了一条前置标定:先算余量的 ICC 与 MDC95,不合格就别进主研究。这条要求方向是对的,但判据本身写歪了三处,而这三处都会把「测不出来」误诊成「这个指标不行」。

第一处,MDC95 与组间差不是一个层级的东西。 MDC95 的定义是:同一个人重复测两次,差值超过这个数才可认为是真变化——系数是 1.96√2 ≈ 2.77 个标准误。它服务的是个体决策。判组间均值差用的是另一样东西:1.96×SE×√(2/n)。两者一除,倍数就是 √n/√2 再乘回 1.96√2 的比例关系——n=20 时 MDC95 是组级门槛的 4.47 倍,n=40 时 6.32 倍,n=60 时 7.75 倍。换句话说,「MDC95 > 组间差 ⇒ 判死」这条判据在 n=40/组时,等价于要求组间差达到 12.4 个标准误。任何真实效应都过不了这一关。文献里这个错法有专名,被反复写过:MDC 是「个体显著变化的最小量」,把它当「组级重要差异」用是误用(PMID 34232924);组级均值差的显著门槛在样本量≥6 且信度≤0.90 时必然低于个体门槛(同源)。

第二处,这条判据其实是一个伪装成信度检查的效应量检查。 把 MDC95 ≤ Δ/2 展开(MDC95 = 2.77×SD×√(1−ICC)),等价于 ICC ≥ 1 − (d/5.54)²,其中 d = Δ/SD。代入具体数:想让 ICC=0.75 通过,得 d ≥ 2.77,即组间差要大到接近 3 个个体标准差。ICC=0.90 时才降到 d ≥ 1.75。也就是说,判据判的从来不是「仪器准不准」,而是「效应大不大」——而效应大小恰恰是研究要回答的问题,不能拿它当前提。

第三处,年龄的解释方差这个数,在 n=40 下本身不稳。 判据设了 30% 与 50% 两条线。可真值固定在 0.30 时,n=40、四个协变量的观测 R² 落在 30% 以下的概率是 27.0%,落在 50% 以上的概率 15.7%——两条线的误判率都不低。真值 0.50 时,观测值跌到 30% 以下的概率 1.4%,但仍有 31% 的机会落在 30%–50% 的中间档。用 40 人给一个回归 R² 划线,划出来的主要是抽样噪声。

更根本的问题在顺序。 源设计是「20-35 岁与 55-70 岁各半」,而 DR2 与年龄的 r²=0.71(PMID 30702975)。这个 r² 在 n=36 的原研究里,95% 置信区间是 [0.505, 0.841]——下界正踩在判据的 50% 线上。这意味着「年龄解释方差 >50% ⇒ 余量是年龄代理」这条判据,在最该用的那个场景里,光凭抽样波动就能来回翻转。而且 ICC 本身依赖人群异质性:个体间差别越小 ICC 越低,同样一台仪器、同样的误差,换个更同质的样本 ICC 就会掉(PMID 29707825)。年龄各半的抽样故意把异质性拉大,ICC 会显得好看;可一旦 z 化把年龄成分扣掉,SD 缩到原来的 0.539(r²=0.71),ICC 又可能跟着掉。先测 ICC、后 z 化,顺序反了。

还有一层,余量这个量本身是「差」而不是「电平」。 它等于两个都带误差的量相减:DR2 是拟合出来的点估计,呼气末容积也带测量误差。两个量的误差在相减时相加而不是抵消。FOT 的实测数据给了量级参考:在潮气量、两倍潮气量、50% 吸气储备量三个容积下,Rrs 与 Xrs 的 ICC 是 0.89–0.98,但到了残气量与 50% 呼气储备量,落到 0.60–0.98(PMID 38036081)——正是本假说关心的低容积端,重复性最差。IOS 的另一组长期随访则显示,电抗参数的 ICC 系统性低于电阻参数(PMID 36131305),更早的经典研究里单次测量 ICC 只有 0.75(非哮喘)与 0.56(哮喘)(PMID 2602594)。用这些数代入:SD=6 个百分点、ICC=0.75,MDC95 约 8.3 个百分点——而源文章举的例子(修炼者 12 个百分点 vs 新手若差 5 个百分点)在这个门槛下必然被「判死」。可同样的数,组级只要 3 人/组就能检出 5 个百分点的差。

那正确的顺序是什么。 不是先算 MDC 再卡关,而是先把三个量分开登记:① 组级最小可检测差(由 SD、ICC、n 三者共同决定,随 n 可调);② 个体级 MDC95(只用于判断单个人是否真变了,不进组间判据);③ 年龄常模 z 化后的残余 SD 与残余 ICC(这才是余量该被比较的尺度)。判据应该写成「组级最小可检测差 ≤ 预期差的 1/2」,而不是「MDC95 ≤ 预期差的 1/2」——前者 n=40、SD=6、ICC=0.75 时是 1.31 个百分点,后者是 8.3 个百分点,差六倍。

证据与局限

已验证: MDC 与 MCID 是两个层级的概念,把个体级 MDC 当组级重要差异用属误用(PMID 34232924);组级均值差的显著门槛在 n≥6 且信度≤0.90 时低于个体门槛(同源);MDC 的经典公式基于经典测验理论、假定全量表误差齐性,IRT 的 cMDC 会随分数位置变化(PMID 35670017);FOT 阻抗参数在不同肺容积下重复性差异明显,低容积端 ICC 降至 0.60–0.98(PMID 38036081);IOS 电抗参数长期重复性低于电阻参数(PMID 36131305);FOT 单次测量 ICC 在非哮喘 0.75、哮喘 0.56(PMID 2602594);ICC 依赖人群异质性,同质样本会压低 ICC,跨人群不可外推(PMID 29707825);信度研究的样本量应按区间精度反解而非按点估计(PMID 24338600、PMID 14673940);行为测量的重测信度估计受样本量强烈影响(PMID 40119099);方差分量在参数空间边界时 LRT 的零分布不是标准 χ²(PMID 16474914)。

部分验证: 「余量」这个终点从未在任何人群被实测过,其 ICC、MDC95、组级最小可检测差全部是本文按 FOT 相邻参数的文献值代入推算,不是实测。年龄 r²=0.71 来自 18 例哮喘 + 18 例健康对照的横断面(PMID 30702975),样本小、且是 DR2 位置而非余量的 r²。本文给出的倍数关系(4.47/6.32/7.75 倍)是代数恒等式,可靠;但代入的具体 SD=6 个百分点是假设值。

待验证: 余量在健康成人(青年/老年分层)的实际 ICC 与 MDC95;年龄 z 化后 ICC 是升是降(理论上 SD 缩小会压 ICC,但年龄成分去掉也可能让个体排序更稳定,方向未定);DR2 检出算法本身的重复性;余量的误差是否真如本文假设的那样在两个分量间相加;组级最小可检测差与源设计的预期差是否留有余量。

L1 网络状态:「该主题尚未进入 L1 对应网络」——CORRESPONDENCE_NETWORK.md 全文 178 行,节点表 2.1/2.2/2.3 三域中均无「呼气末肺容积」「气道闭合」「DR2 / 去复张拐点」「余量」这类节点;生理侧只列有「呼吸率 / 呼吸模式」与「胃肠蠕动(气沉丹田候选物)」,物理侧列有「相位 / 节律」,三者均未与易学侧任何节点连边。边表 3.1–3.5 仅登记五行↔五脏/五色/五音/五方/五季/五志、八卦↔五行、天干地支↔五行、纳音↔频率(E-050,状态 open、现代证据栏写「尚无任何可测来源」);与肺相关的唯一一条是 E-004(金 → 肺,传统出处《素问·阴阳应象大论》,现代证据栏「待补」,层级 L1,状态 open)。EDGE_TABLE_science-yixue.md 中「丹田」仅 51 篇文章计数、「气功」48 篇,无层级与状态判定。故本文封顶 C,全部机制表述为方法学推演,不得读作已验证的生理机制。

相关阅读

证据等级: C
参考文献: PMID 30702975, PMID 34232924, PMID 35670017, PMID 38036081, PMID 36131305, PMID 2602594, PMID 29707825, PMID 24338600, PMID 14673940, PMID 40119099, PMID 16474914


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Is \”Remnant\” a Qualified Endpoint: Level Mixing in MDC95 and the Inevitable Confounding of Age

Evidence level: C

Before asking whether “the margin is larger for practitioners,” one must first ask whether “this margin is measured accurately within this design”—yet the common formulation answers this question incorrectly: it applies an individual-level threshold to assess group-level differences.

Main Text

The previous entry reclassified “sinking without collapsing” from an X5-level metric to “the distance from end-expiration to DR2,” and provided a prerequisite calibration: first calculate the ICC and MDC95 of the margin; if they fail, do not proceed to the main study. This direction is correct, but the criteria themselves are misstated in three places, all of which risk misdiagnosing “cannot be measured” as “this indicator is invalid.”

First, MDC95 and group differences operate at different levels. The definition of MDC95 is: a difference exceeding this value between two repeated measurements on the same individual is considered true change—the coefficient is 1.96√2 ≈ 2.77 standard errors. It serves individual decision-making. Assessing the mean difference between groups uses a different metric: 1.96×SE×√(2/n). Dividing the two yields a ratio of √n/√2 multiplied by 1.96√2. For n=20, MDC95 is 4.47 times the group-level threshold; for n=40, 6.32 times; for n=60, 7.75 times. In other words, the criterion “MDC95 > group difference ⇒ reject” implies that for n=40 per group, the group difference must reach 12.4 standard errors. Any true effect would fail this test. This error has a specific name in the literature, repeatedly noted: MDC is “the minimum amount of individual significant change,” using it as “group-level important difference” is misuse (PMID 34232924); the significance threshold for group mean differences is necessarily lower than the individual threshold when sample size ≥6 and reliability ≤0.90 (same source).

Second, this criterion is actually an effect size check disguised as a reliability check. Expanding MDC95 ≤ Δ/2 (where MDC95 = 2.77×SD×√(1−ICC)) is equivalent to ICC ≥ 1 − (d/5.54)², where d = Δ/SD. Substituting specific values: to pass with ICC=0.75, we need d ≥ 2.77, meaning the group difference must be nearly 3 individual standard deviations. ICC=0.90 only lowers this to d ≥ 1.75. Thus, the criterion never judges “how accurate the instrument is,” but rather “how large the effect is”—and effect size is precisely the question the study must answer, not its premise.

Third, the explained variance of age is unstable itself at n=40. The criterion sets two lines: 30% and 50%. If the true value is fixed at 0.30, with n=40 and four covariates, the probability that the observed R² falls below 30% is 27.0%, and above 50% is 15.7%—both error rates are substantial. At true value 0.50, the probability of dropping below 30% is only 1.4%, yet there remains a 31% chance of falling into the intermediate 30%–50% range. Drawing a regression R² line with only 40 people primarily captures sampling noise.

The more fundamental issue lies in the order. The source design is “half 20–35 years old, half 55–70 years old,” while DR2 and age have r²=0.71 (PMID 30702975). This r² in the original study with n=36 has a 95% confidence interval of [0.505, 0.841]—the lower bound exactly hits the criterion’s 50% line. This means “age-explained variance >50% ⇒ margin is an age proxy” flips back and forth solely due to sampling fluctuation in the very scenario where it should apply. Moreover, ICC itself depends on population heterogeneity: smaller inter-individual differences yield lower ICC; with the same instrument and error, switching to a more homogeneous sample lowers ICC (PMID 29707825). Halving the age distribution intentionally increases heterogeneity, making ICC appear favorable; but once z-scoring removes the age component, SD shrinks to 0.53 of its original value (r²=0.71), and ICC may drop accordingly. Measuring ICC first, then z-scoring, reverses the proper order.

Furthermore, the margin itself is a “difference,” not a “level.” It equals the subtraction of two quantities each carrying error: DR2 is a fitted point estimate, and end-expiratory volume also carries measurement error. Errors add rather than cancel when subtracting. FOT real-world data provides scale reference: at tidal volume, double tidal volume, and 50% inspiratory reserve volume, Rrs and Xrs ICC ranges from 0.89–0.98, but at residual volume and 50% expiratory reserve volume, it drops to 0.60–0.98 (PMID 38036081)—precisely the low-volume end of interest in this hypothesis. IOS long-term follow-up shows reactive parameters have systematically lower ICC than resistive parameters (PMID 36131305); in earlier classic studies, single-measurement ICC was only 0.75 (non-asthmatic) and 0.56 (asthmatic) (PMID 2602694). Substituting these values: SD=6 percentage points, ICC=0.75, MDC95 ≈ 8.3 percentage points—yet the source article’s example (practitioner 12 percentage points vs novice difference of 5 percentage points) would inevitably be “rejected” under this threshold. However, with the same numbers, group-level differences of just 3 people/group can detect a 5 percentage point difference.

So what is the correct order? Not calculating MDC first to set a gate, but registering three quantities separately: ① minimum detectable group difference (determined jointly by SD, ICC, and n, adjustable with n); ② individual-level MDC95 (used only to judge whether a single person truly changed, not for group comparison); ③ residual SD and residual ICC after z-scoring age (this is the scale on which margin should be compared). The criterion should read “minimum detectable group difference ≤ half the expected difference,” not “MDC95 ≤ half the expected difference”—the former yields 1.31 percentage points for n=40, SD=6, ICC=0.75, versus 8.3 percentage points for the latter—a sixfold difference.

Evidence and Limitations

Verified: MDC and MCID are concepts at different levels; using individual-level MDC as group-level important difference is misuse (PMID 34232924); the significance threshold for group mean differences is lower than individual thresholds when n≥6 and reliability≤0.90 (same source); the classic MDC formula assumes classical test theory with uniform full-scale error, whereas IRT cMDC varies with score position (PMID 35670017); FOT impedance parameters show marked repeatability differences across lung volumes, with low-volume ICC dropping to 0.60–0.98 (PMID 38036081); IOS reactive parameters have lower long-term repeatability than resistive parameters (PMID 36131305); FOT single-measurement ICC is 0.75 for non-asthmatics and 0.56 for asthmatics (PMID 2602694); ICC depends on population heterogeneity, homogeneous samples depress ICC, cross-population extrapolation is invalid (PMID 29707825); reliability study sample size should be derived from interval precision rather than point estimates (PMID 24338600, PMID 14673940); test-retest reliability estimation for behavioral measures is strongly influenced by sample size (PMID 40119099); variance components at parameter space boundaries do not follow standard χ² distribution under LRT (PMID 16474914).

Partially Verified: The endpoint “margin” has never been directly measured in any population; its ICC, MDC95, and minimum detectable group difference are all derived by substituting FOT adjacent parameter values from literature, not measured. Age r²=0.71 comes from a cross-sectional study of 18 asthmatics and 18 healthy controls (PMID 30702975), with small sample size and representing DR2 position rather than margin r². The multiplicative ratios (4.47/6.32/7.75 times) are algebraic identities, reliable; however, the substituted SD=6 percentage points is an assumed value.

To Be Verified: Actual ICC and MDC95 of margin in healthy adults (stratified by youth/elderly); whether ICC rises or falls after z-scoring age (theoretically SD reduction depresses ICC, but removing age components may stabilize individual ranking, direction uncertain); repeatability of the DR2 detection algorithm itself; whether margin error truly adds between components as assumed; whether minimum detectable group difference leaves sufficient margin relative to the source design’s expected difference.

L1 Network Status: “This topic has not yet entered the L1 corresponding network”—CORRESPONDENCE_NETWORK.md contains 178 lines, and node tables 2.1/2.2/2.3 across three domains lack nodes such as “end-expiratory lung volume,” “airway closure,” “DR2 / derecruitment inflection point,” or “margin”; the physiological side lists only “respiratory rate / respiratory pattern” and “gastrointestinal motility (candidate for Qi Chen Dan Tian),” while the physical side lists “phase / rhythm,” none of which connect to any Yijing-side nodes. Edge tables 3.1–3.5 only register Five Phases ↔ Five Organs/Five Colors/Five Tones/Five Directions/Five Seasons/Five Emotions, Eight Trigrams ↔ Five Phases, Heavenly Stems and Earthly Branches ↔ Five Phases, Na Yin ↔ Frequency (E-050, status open, modern evidence column states “no measurable source yet”); the only lung-related entry is E-004 (Metal → Lung, traditional source Su Wen · Yin Yang Ying Xiang Da Lun), with modern evidence column “to be supplemented,” level L1, status open. EDGE_TABLE_science-yixue.md lists only 51 articles for “Dan Tian” and 48 for “Qigong,” without level or status determination. Therefore, this paper caps at C; all mechanism descriptions are methodological derivations and must not be read as verified physiological mechanisms.

Related Reading

Evidence Level: C
References: PMID 30702975, PMID 34232924, PMID 35670017, PMID 38036081, PMID 36131305, PMID 2602694, PMID 29707825, PMID 24338600, PMID 14673940, PMID 40119099, PMID 16474914


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *